000 | 01480 a2200457 4500 | ||
---|---|---|---|
005 | 20250517190548.0 | ||
264 | 0 | _c20180718 | |
008 | 201807s 0 0 eng d | ||
022 | _a1791-3004 | ||
024 | 7 |
_a10.3892/mmr.2017.8185 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWu, Guixia | |
245 | 0 | 0 |
_aLiposome encapsulated luteolin showed enhanced antitumor efficacy to colorectal carcinoma. _h[electronic resource] |
260 |
_bMolecular medicine reports _cFeb 2018 |
||
300 |
_a2456-2464 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aChemoprevention |
650 | 0 | 4 | _aColorectal Neoplasms |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 | _aDrug Liberation |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLiposomes |
650 | 0 | 4 |
_aLuteolin _xadministration & dosage |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aTissue Distribution |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aLi, Jing | |
700 | 1 | _aYue, Jinqiao | |
700 | 1 | _aZhang, Shuying | |
700 | 1 | _aYunusi, Kurexi | |
773 | 0 |
_tMolecular medicine reports _gvol. 17 _gno. 2 _gp. 2456-2464 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3892/mmr.2017.8185 _zAvailable from publisher's website |
999 |
_c27856192 _d27856192 |